Clinical Trial Update: Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating treosulfan-based conditioning in pediatric patients with hematological malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Juvenile Myelomonocytic Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• treosulfan-based conditioning

Snippet

Sponsor: medac GmbH | Conditions: Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML) | Phase 2 | Status: COMPLETED